Note: Odyssey Therapeutics withdrew its IPO plans in a letter to the SEC dated June 10, 2025. Odyssey, a clinical biotech focused on autoimmune and inflammatory diseases, including ulcerative colitis, filed its S-1 on Jan. 17, 2025, without disclosing the IPO’s terms. Odyssey is a clinical-stage biopharmaceutical company led by a team and board of […]

(Note: This is a NASDAQ uplisting – a public offering – and NOT an IPO. The stock currently trades on the OTCQB.) We are a pioneer in the development, production and marketing of an innovative visualization and artificial intelligence, or AI, solution that deploys small cameras to monitor critical safety components in hard-to-reach locations and […]

(Incorporated in Delaware) Note: Wellgistics Health (WGRX Proposed) was formerly known as Danam Health.  Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division […]

We are a newly organized blank check company. (Incorporated in the Cayman Islands) We were founded by two Greek shipping executives, Prokopios Tsirigakis and George Syllantavos. They are the co-CEOs of Nautilus Energy Management, a maritime energy services company.  (Note: Stellar V Capital Corp. disclosed the terms for its SPAC IPO on Dec. 4, 2024, in […]

We are a clinical biopharmaceutical company developing MET-097i as an injectable treatment for obesity in a Phase I/Phase 2 clinical trial with overweight or obese healthy volunteers. (Incorporated in Delaware) We are developing next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Obesity and overweight are […]

(Incorporated in Delaware) We specialize in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (“DoD”) and space sector […]

We provide enterprises with customized identity security software. (Incorporated in Delaware) We offer a range of solutions to meet the varied needs of our customers across multiple deployment options, including Identity Security Cloud, our SaaS-based cloud solution built on our unified platform, Atlas, and IdentityIQ, our customer-hosted identity security solution. These solutions are designed to […]

We are a blank check company, incorporated in 2024, with a focus on the technology sector, specifically semiconductors and systems solutions. (Incorporated in the Cayman Islands) Initially, we will look at companies that are poised for growth, led by a highly regarded management team, with an enterprise value in the range of $200 million to […]

We are a blank check company. (Incorporated in the Cayman Islands) Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location. We do not have any specific business combination under consideration.  As a blank check company incorporated for the purpose of effecting a business combination, we […]

Ascentage Pharma Group International, or Ascentage Pharma, is offering 7,325,000 American depositary shares, or ADSs. Each ADS represents four ordinary shares. Note: This is our initial public offering in the United States, and no public market currently exists for the ADSs. Our ordinary shares, par value US$0.0001 per share, have been listed on The Stock Exchange […]